Status: Recruiting
A Study of JMT203 in Patients With Cancer Cachexia
A Phase Ia/II, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of JMT203 in Patients with Cancer Cachexia
Participants needed: 307
Trial details
Phase: Phase 1, Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Shanghai JMT-Bio Inc.Updated: May 22, 2026Locations: 1
Eligibility criteria
Age ≥ 18 years old; [+11]
Presence of reversible causes leading to decreased food intake; [+20]